Targeting Iron Responsive Elements in Alzheimer's Disease
Author Information
Author(s): Khan Mateen A.
Primary Institution: Alfaisal University, Riyadh, Saudi Arabia
Hypothesis
Can targeting iron responsive elements (IREs) of APP mRNA provide a novel therapeutic approach for controlling amyloid-β production in Alzheimer's disease?
Conclusion
Targeting IREs in APP mRNA may help regulate amyloid-β production and offer new therapeutic strategies for Alzheimer's disease.
Supporting Evidence
- Iron misregulation is linked to the development of Alzheimer's disease.
- Modulating APP expression through IREs may provide therapeutic benefits.
- Excess iron in the brain is associated with increased amyloid-β aggregation.
Takeaway
This study suggests that by changing how a specific part of a gene works, we might be able to help treat Alzheimer's disease by controlling a harmful protein.
Methodology
The review discusses the structural and functional aspects of IREs in APP mRNA and their implications for Alzheimer's disease therapy.
Limitations
The review is based on existing literature and does not present new experimental data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website